期刊文献+

地龙酸性部位对小鼠过敏性哮喘模型的抗炎和抗过敏作用 被引量:25

Anti-inflammatory and anti-allergic effects of acidic fraction of Pheratima extract in asthma mice induced by ovalbumin
下载PDF
导出
摘要 目的:以小鼠过敏性哮喘模型,探讨地龙酸性部位对过敏性哮喘的治疗作用,并为进一步精制提供依据。方法:通过卵蛋白(OVA)皮下注射致敏,雾化吸入激发的方法,建立哮喘特异性免疫治疗的小鼠模型。通过检测支气管灌洗液(BALF)中的嗜酸性粒细胞(EOS)计数和ELISA法检测BALF中IgE,IL-4,IL-5,IL-13和IFN-γ,考察模型动物与过敏性哮喘相关的炎症细胞水平和免疫系统的Th1/Th2平衡,及药物对它们的影响。结果:较正常小鼠,过敏性哮喘模型小鼠BALF中的嗜酸性粒细胞(eosinophil,EOS)计数显著升高(P<0.01),IgE,IL-4,IL-5,IL-13水平显著升高(P<0.01)和IFN-γ显著降低(P<0.01)。地龙酸性部位组(S)和30%乙醇洗脱(S30)组有显著的抑制EOS计数升高(P<0.01),明显抑制IgE,IL-4,IL-5,IL-13水平升高(P<0.05),和显著抑制IFN-γ降低的作用(P<0.01)。结论:实验提示抑制EOS的分泌和调整Th1/Th2平衡可能是地龙治疗过敏性哮喘的机制之一,S 30在这上述指标上能够较好体现等剂量S的药效作用。 Objective: To explore the effects of acidic fraction of Pheratima extract in an ovalbumin (OVA) induced asthma mouse model, and to provide the experimental evidences for the anti-asthmatic application of Pheratima extract with further purification and development. Method: Mice model of allergic asthma was established through the OVA challenge. To investigate the inflammatory cell level and Th1/Th2 levels as well as the therapeutic effects of acidic fraction from Pheratima extract, cell count of bronchoalveolar lavage fluid (BALF) was performed to evaluate the secretion of eosinophils (EOS) cells, and IgE, IL-4, IL-5, IL-13, IFN-γ levels were detected by ELISA. Result: Compared with control group, the EOS count of BALF in the model group was remarkably increased (P 〈 0. 01 ), and IgE, IL-4, IL-5, IL-13 levels were also increased (P 〈 0. 01 ), while IFN-γ decreased (P 〈 0. 01 ). Acidic fraction from Pheratima (S) extract and its 30% ethanol washed fraction (S30) significantly inhibited the increase of EOS count (P 〈 0. 01 ), decreased the IgE, IL-4, IL-5, IL-13 levels (P 〈 0.05 ), and inhibited the decrease of IFN-γ level (P 〈 0. 01 ). Conclusion: The results indicate that inhibition of the EOS secretion and balancing of the altered Th1/Th2 levels may be important mechanisms of Pheratima's therapeutic effect in asthmatic mice model, and S30 is pharmacologically effective as evaluated with the above mentioned parameters, as a representative fraction of the Pheratima extract.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第19期2249-2252,共4页 China Journal of Chinese Materia Medica
基金 上海市科委中药专项课题(06DZ19722)
关键词 过敏性哮喘 小鼠 地龙 allergic asthma mice pheratima
  • 相关文献

参考文献15

  • 1Corrigan C J, Kay A B. The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease [ J ]. Am Rev Respir Dis, 1991,143 (5) : 1165.
  • 2Barnes P J. Endogenous inhibitory mechanism in asthma[ J]. Am J Respir Crit Care Med, 2000,161 (3) :S176.
  • 3Busse W W, Sedgwick J B. Eosinophils in asthma [ J ]. Ann Allergy, 1992,68(2) :286.
  • 4Fernandez-Rodriguez S, Ford W R, Broadley K J, et al. Establish the phenotype in novel acute and chronic murine models of allergic asthma [ J ]. International Immunopharmacol, 2008,8 (5) :756.
  • 5Mehta A K, Gaur S N, Arora N, et al. Effect of choline chloride in allergen-induced mouse model of airway inflammation[J]. Eur Respir J, 2007,30(4) :662.
  • 6中国药典.一部[S].2005:223.
  • 7襄萍,徐朝晖,战光绪,吴大正,邱明丰,贾伟.药对麻黄地龙配比及平喘作用机制的研究[J].中国中药杂志,2006,31(3):236-239. 被引量:15
  • 8Chu X, Xu Z, Jia W, et al. In vitro and in vivo evaluation of the anti-asthmatic activities of fractions from Pheretima [ J ] J Ethnopharmacol, 2007,111 (3) :490.
  • 9Ram A, Das M, Gangal S V, et al. Para-bromophenacyl bromide alleviates airway h and modulates cytokines, IgE and eosinophils levels in ovalbumin-sensitized and-challenged mice[J]. Int Immunopharmacol, 2004,4(13) :1697.
  • 10程晓明,钱桂生,王长征.哮喘特异性免疫治疗诱导的卵蛋白致敏小鼠模型T细胞无能机制的探讨[J].细胞与分子免疫学杂志,2005,21(4):482-485. 被引量:10

二级参考文献27

  • 1喻平瀛,金永祥.麻黄地龙汤治疗支气管哮喘53例疗效观察[J].甘肃中医,1995,8(3):13-14. 被引量:1
  • 2舒茂琴,中华结核和呼吸杂志,1993年,16卷,30页
  • 3杨玉,中华结核和呼吸杂志,1993年,16卷,30页
  • 4周史琴,中药学,1990年
  • 5徐叔云,药理实验方法学,1982年
  • 6Basomba A, Tabar AI, de Rojas DH, et al. Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients[ J]. J Allergy Clin Immunol, 2002, 109 : 943 -948.
  • 7Adkinson NF Jr, Eggleston PA, Eney D, et al. A controlled trial of immunotherapy for asthma in allergic children [ J]. N Engl J Med,1997, 336(5) : 324 -331.
  • 8Havinga W. Risk of asthma[J]. Lancet, 2001,357(9252) : 313 -314.
  • 9Samoilova EB, Horton JL, Zhang H, et al. CTLA-4 is required for the induction of high dose oral tolerance [ J]. Int Immunol, 1998, 10(4) : 491 -498.
  • 10Frauwirth KA, Alegre ML, Thompson CB. Induction of T cell anergy in the absence of CTLA-4/B7 interaction[ J ]. J Immunol, 2000, 164(6) : 2987 -2993.

共引文献387

同被引文献383

引证文献25

二级引证文献254

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部